Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.

Gera L, Stewart JM, Fortin JP, Morissette G, Marceau F.

Int Immunopharmacol. 2008 Feb;8(2):289-92. doi: 10.1016/j.intimp.2007.06.006. Epub 2007 Jul 5.

PMID:
18182242
2.

Bradykinin-related compounds as new drugs for cancer and inflammation.

Stewart JM, Gera L, Chan DC, Bunn PA Jr, York EJ, Simkeviciene V, Helfrich B.

Can J Physiol Pharmacol. 2002 Apr;80(4):275-80.

PMID:
12025961
3.

Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.

Drapeau G, Audet R, Levesque L, Godin D, Marceau F.

J Pharmacol Exp Ther. 1993 Jul;266(1):192-9.

PMID:
8392550
4.

Potent, long-acting bradykinin antagonists for a wide range of applications.

Stewart JM, Gera L, Chan DC, Whalley ET, Hanson WL, Zuzack JS.

Can J Physiol Pharmacol. 1997 Jun;75(6):719-24. Review.

PMID:
9276154
5.

A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.

Morissette G, Fortin JP, Otis S, Bouthillier J, Marceau F.

J Pharmacol Exp Ther. 2004 Dec;311(3):1121-30. Epub 2004 Jul 26.

6.

Bradykinin receptors and their antagonists.

Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ.

Eur J Pharmacol. 1998 May 1;348(1):1-10. Review.

PMID:
9650825
7.

Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.

Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F.

J Pharmacol Exp Ther. 2005 Sep;314(3):1169-76. Epub 2005 May 26.

8.

Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.

Gera L, Fortin JP, Adam A, Stewart JM, Marceau F.

J Pharmacol Exp Ther. 2006 Apr;317(1):300-8. Epub 2005 Dec 20.

9.

Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.

MacNeil T, Feighner S, Hreniuk DL, Hess JF, Van der Ploeg LH.

Can J Physiol Pharmacol. 1997 Jun;75(6):735-40.

PMID:
9276157
10.

Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.

Miskolzie M, Gera L, Stewart JM, Kotovych G.

J Biomol Struct Dyn. 2002 Feb;19(4):585-93.

PMID:
11843620
11.

Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.

Lin KS, Amouroux G, Pan J, Zhang Z, Jenni S, Lau J, Liu Z, Hundal-Jabal N, Colpo N, Bénard F.

J Nucl Med. 2015 Apr;56(4):622-7. doi: 10.2967/jnumed.114.152132. Epub 2015 Mar 5.

12.

DesArg9-D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin (desArg10-[Hoe140]) is a potent bradykinin B1 receptor antagonist.

Wirth K, Breipohl G, Stechl J, Knolle J, Henke S, Schölkens B.

Eur J Pharmacol. 1991 Nov 26;205(2):217-8.

PMID:
1667388
13.

Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.

Zhang Z, Amouroux G, Pan J, Jenni S, Zeisler J, Zhang C, Liu Z, Perrin DM, Bénard F, Lin KS.

Mol Pharm. 2016 Aug 1;13(8):2823-32. doi: 10.1021/acs.molpharmaceut.6b00428. Epub 2016 Jul 14.

PMID:
27348517
14.

A fluorescent version of the bradykinin B2 receptor antagonist B-9430: pharmacological characterization and use in live cell imaging.

Bawolak MT, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F.

Peptides. 2008 Sep;29(9):1626-30. doi: 10.1016/j.peptides.2008.05.007. Epub 2008 May 17.

PMID:
18565624
15.

(18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.

Liu Z, Amouroux G, Zhang Z, Pan J, Hundal-Jabal N, Colpo N, Lau J, Perrin DM, Bénard F, Lin KS.

Mol Pharm. 2015 Mar 2;12(3):974-82. doi: 10.1021/acs.molpharmaceut.5b00003. Epub 2015 Feb 9.

PMID:
25629412
16.

Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.

Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA Jr, Taraseviciene-Stewart L.

Peptides. 2005 Aug;26(8):1288-91.

PMID:
15878795
17.

Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.

Goodfellow VS, Marathe MV, Kuhlman KG, Fitzpatrick TD, Cuadrado D, Hanson W, Zuzack JS, Ross SE, Wieczorek M, Burkard M, Whalley ET.

J Med Chem. 1996 Mar 29;39(7):1472-84.

PMID:
8691478
18.

Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.

Stewart JM, Gera L, Chan DC, Whalley ET, Hanson WL, Zuzack JS.

Immunopharmacology. 1997 Jun;36(2-3):167-72. Review.

PMID:
9228542
19.

Supplemental Content

Support Center